Biogen (BIIB)

Cash & Short-Term Investments

$1.29B

Quarterly · Period ending: · USD

BIIB logo

BIIB Cash & Short-Term Investments

Latest reported$1.29B
BIIB Quarterly Cash & Short-Term Investments ($53.50M → $1.29B)
High-resolution chart · PNG

BIIB cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
1,285,000,000
4,282,700,000
3,815,700,000
3,960,400,000
2,758,800,000
2,598,300,000
2,375,000,000
1,699,200,000
1,908,900,000
1,074,400,000
1,049,900,000
2,287,900,000
6,078,300,000
5,041,300,000
4,892,800,000
4,911,100,000
4,797,900,000
3,751,700,000
3,802,500,000
2,955,100,000
3,050,800,000
2,537,500,000
2,610,100,000
3,579,800,000
4,327,600,000
3,860,400,000
4,475,900,000
4,437,400,000
2,952,200,000
3,909,000,000
3,538,000,000
4,428,400,000
3,224,200,000
5,916,000,000
3,689,000,000
3,508,300,000
2,893,000,000
2,880,200,000
4,895,100,000
4,316,000,000
3,796,800,000
3,585,400,000
3,428,500,000
5,842,502,000
2,368,673,000
2,151,997,000
1,845,384,000
1,861,346,000
1,573,066,000
1,260,211,000
1,222,729,000
668,693,000
667,670,000
3,631,302,000
1,705,710,000
1,605,794,000
1,406,050,000
1,276,612,000
1,690,657,000
1,519,521,000
1,326,744,000
1,228,545,000
1,207,744,000
824,592,000
969,672,000
1,152,674,000
1,263,724,000
1,407,676,000
1,623,074,000
1,401,323,000
1,371,417,000
1,386,799,000
892,252,000
986,400,000
1,183,503,000
671,347,000
1,802,717,000
1,127,579,000
902,691,000
661,019,000
713,774,000
849,355,000
850,753,000
611,398,000
927,453,000
1,151,881,000
1,057,942,000
445,880,000
741,375,000
761,547,000
835,959,000
925,545,000
857,895,000
812,381,000
787,774,000
828,397,000
793,465,000
807,555,000
798,107,000
789,729,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.